Woodline Partners’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
6CM
PFCS
VCM
CCM
GCGM
DMC
MC
MCM
Woodline Partners's GUTS Position: Q1 2026 in Review
Woodline Partners reduced its Fractyl Health (GUTS) stake by 59% in Q1 2026, selling an estimated $3.01M and leaving 2,241,679 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #884.
Woodline Partners first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.1M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.
- Woodline Partners held 2,241,679 shares of Fractyl Health worth $1.03M as of Q1 2026.
- Woodline Partners sold 3,265,092 Fractyl Health shares in Q1 2026, an estimated $3.01M.
- Fractyl Health made up ﹤0.01% of Woodline Partners's portfolio in Q1 2026, its #884 holding.
- Woodline Partners first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
- Woodline Partners's Fractyl Health position peaked at $12.1M in Q4 2025.
- 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.